Ruihe Lin, MD

Pathology and Laboratory Medicine
Accepting new patients
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP
View 3 additional locations
Call 800-789-7366
Headshot of Ruihe Lin, MD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Pathology and Laboratory Medicine

My education and training

  • Medical School: Shanghai Medical University
  • Residency: Thomas Jefferson University Hospital
  • Fellowship: University of Pennsylvania Health System
  • Fellowship: Johns Hopkins University School of Medicine

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Lin is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Hrizat AS, Lin R, Eberle-Singh J, O'Neill R, Xia Y, Testa JR, Uzzo R, McCue PA, Yang H, Li L. Tumor infiltrating T-cells and loss of expression of SWI/SNF genes in varying stages of clear cell renal cell carcinoma. , Pathol Res Pract. , 266: 2025,155774

Lin R, Kenyon A, Wang ZX, Cai J, Iacovitti L, Kenyon LC. Pilocytic astrocytoma harboring a novel GNAI3-BRAF fusion. , Neuropathology, 43(5): 2023,391-395

Lin R, Mallick AB, Wang ZX, Brown SA, Lu B, Jiang W. Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy. , Diagn Pathol., 18(1): 2023,116

Lin R, Flerova E, Wamsley CE, McCue PA, Lallas CD, Jiang W, Huang J, Wang ZX, Li L. Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification. , Genes Chromosomes Cancer, 62(6): 2023,353-360

Hrizat A, Lin R, Xiang Y, Holtmeyer C, Koob K, McCue PA, Yang H, Li L Tumor infiltrating T-cells and mutations of SWI/SNF genes in varying stages of ccRCC , The United States & Canadian Academy of Pathology (USCAP) Annual Meeting, New Orleans, Louisiana.: 2023

Lin R, Wang ZX, Cottrill E, Badjatia N, Gargano SM. Patient with multiple genetically distinct thyroid nodules including papillary thyroid carcinoma harboring novel YWHAG-BRAF fusion. , Cancer Genet., no volume(no issue): 2022,266-267:51-56

Lin R, Wang ZX, Kenyon L Pilocytic astrocytoma harboring a novel GNAI3-BRAF fusion , The American Association of Neuropathologists Meeting, Bonita Spring, Florida.: 2022

Lin R, Joneja U, Shaikh H, Kenyon L Cocaine-induced multifocal leukoencephalopathy: A case report , The American Association of Neuropathologists Meeting, St. Louis, Missouri.: 2021

Lin R, Wang ZX, Brown S, Basu Mallick A, Jiang W Identification of STRN-NTRK2 rearrangement in a high grade sarcoma, with good response to first-line Larotrectinib therapy , The American Society for Clinical Pathology (ASCP) Annual Meeting, September, 2020: 2020

Schmidt RF, Theofanis TN, Lang MJ, Stricsek GP, Lin R, Lebrun A, Hooper DC, Rosenwasser RH, Sharan AD, Iacovitti L. Sphenopalatine ganglion stimulation is a reversible and frequency-dependent modulator of the blood-brain barrier. , Brain Res. , 1718(No issue): 2019,231-241